{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:11:15Z","timestamp":1792030275498,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"FP7","award":["222887"],"award-info":[{"award-number":["222887"]}]},{"name":"FP7","award":["01ED1201A"],"award-info":[{"award-number":["01ED1201A"]}]},{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","award":["NRZ 1369-341"],"award-info":[{"award-number":["NRZ 1369-341"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005224","name":"Deutsches Zentrum f\u00fcr Neurodegenerative Erkrankungen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["AGL2015-71764"],"award-info":[{"award-number":["AGL2015-71764"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s12035-017-0479-5","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T23:04:20Z","timestamp":1490051060000},"page":"2249-2257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Validation of \u03b1-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease"],"prefix":"10.1007","volume":"55","author":[{"given":"Franc","family":"Llorens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Karch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Gotzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silja","family":"K\u00f6chy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Knipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Golanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Sikorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel P.","family":"Liberski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"S\u00e1nchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"Mollenhauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,21]]},"reference":[{"key":"479_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","volume":"11","author":"G Puoti","year":"2012","unstructured":"Puoti G, Bizzi A, Forloni G et al (2012) Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 11:618\u2013628. doi:\n10.1016\/S1474-4422(12)70063-7","journal-title":"Lancet Neurol"},{"key":"479_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/bmb\/66.1.213","volume":"66","author":"P Gambetti","year":"2003","unstructured":"Gambetti P, Kong Q, Zou W et al (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66:213\u2013239. doi:\n10.1093\/bmb\/66.1.213","journal-title":"Br Med Bull"},{"key":"479_CR3","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/brain\/awm063","volume":"130","author":"U Heinemann","year":"2007","unstructured":"Heinemann U, Krasnianski A, Meissner B et al (2007) Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 130:1350\u20131359. doi:\n10.1093\/brain\/awm063","journal-title":"Brain"},{"key":"479_CR4","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1212\/CON.0000000000000319","volume":"22","author":"MD Geschwind","year":"2016","unstructured":"Geschwind MD (2016) Rapidly progressive dementia. Contin Lifelong Learn Neurol 22:510\u2013537. doi:\n10.1212\/CON.0000000000000319","journal-title":"Contin Lifelong Learn Neurol"},{"key":"479_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/archneurol.2011.189","volume":"68","author":"C Schmidt","year":"2011","unstructured":"Schmidt C, Wolff M, Weitz M et al (2011) Rapidly progressive Alzheimer disease. Arch Neurol 68:1124\u20131130. doi:\n10.1001\/archneurol.2011.189","journal-title":"Arch Neurol"},{"key":"479_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1212\/CPJ.0b013e31826b2ae8","volume":"2","author":"RW Paterson","year":"2012","unstructured":"Paterson RW, Takada LT, Geschwind MD (2012) Diagnosis and treatment of rapidly progressive dementias. Neurol Clin Pract 2:187\u2013200. doi:\n10.1212\/CPJ.0b013e31826b2ae8","journal-title":"Neurol Clin Pract"},{"key":"479_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1212\/01.wnl.0000230159.67128.00","volume":"67","author":"P Sanchez-Juan","year":"2006","unstructured":"Sanchez-Juan P, Green A, Ladogana A et al (2006) CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67:637\u2013643. doi:\n10.1212\/01.wnl.0000230159.67128.00","journal-title":"Neurology"},{"key":"479_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/ana.410430109","volume":"43","author":"I Zerr","year":"1998","unstructured":"Zerr I, Bodemer M, Gefeller O et al (1998) Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 43:32\u201340. doi:\n10.1002\/ana.410430109","journal-title":"Ann Neurol"},{"key":"479_CR9","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1093\/brain\/aws238","volume":"135","author":"K Stoeck","year":"2012","unstructured":"Stoeck K, Sanchez-Juan P, Gawinecka J et al (2012) Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain 135:3051\u20133061. doi:\n10.1093\/brain\/aws238","journal-title":"Brain"},{"key":"479_CR10","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1212\/WNL.58.2.192","volume":"58","author":"M Otto","year":"2002","unstructured":"Otto M, Wiltfang J, Cepek L et al (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58:192\u2013197. doi:\n10.1212\/WNL.58.2.192","journal-title":"Neurology"},{"key":"479_CR11","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/jnnp.2009.197962","volume":"81","author":"G Chohan","year":"2010","unstructured":"Chohan G, Pennington C, Mackenzie JM et al (2010) The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 81:1243\u20131248. doi:\n10.1136\/jnnp.2009.197962","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"479_CR12","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neuroscience.2016.02.057","volume":"322","author":"MJ Leit\u00e3o","year":"2016","unstructured":"Leit\u00e3o MJ, Baldeiras I, Almeida MR et al (2016) Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3?? Assay. Neuroscience 322:398\u2013407. doi:\n10.1016\/j.neuroscience.2016.02.057","journal-title":"Neuroscience"},{"key":"479_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1471-2377-11-133","volume":"11","author":"MB Coulthart","year":"2011","unstructured":"Coulthart MB, Jansen GH, Olsen E et al (2011) Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol 11:133. doi:\n10.1186\/1471-2377-11-133","journal-title":"BMC Neurol"},{"key":"479_CR14","doi-asserted-by":"crossref","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamanaka H, Shirabe S, Yamada M, Mizusawa H, Kitamoto T, Klug G, McGlade A, Collins SJ, Nishida N (2011) Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17(2):175--8","DOI":"10.1038\/nm.2294"},{"key":"479_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02451-14","author":"CD Orru","year":"2015","unstructured":"Orru CD, Groveman BR, Hughson AG et al (2015) Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. MBio. doi:\n10.1128\/mBio.02451-14","journal-title":"MBio"},{"key":"479_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ana.23589","volume":"72","author":"LI McGuire","year":"2012","unstructured":"McGuire LI, Peden AH, Orru CD et al (2012) Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol 72:278\u2013285. doi:\n10.1002\/ana.23589","journal-title":"Ann Neurol"},{"key":"479_CR17","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s12035-015-9133-2","volume":"53","author":"M Cramm","year":"2016","unstructured":"Cramm M, Schmitz M, Karch A et al (2016) Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol 53:1896\u20131904. doi:\n10.1007\/s12035-015-9133-2","journal-title":"Mol Neurobiol"},{"key":"479_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3233\/JAD-143099","volume":"45","author":"C Pan","year":"2015","unstructured":"Pan C, Korff A, Galasko D et al (2015) Diagnostic values of cerebrospinal fluid T-tau and A\u03b242 using Meso scale discovery assays for Alzheimer\u2019s disease. J Alzheimers Dis 45:709\u2013719. doi:\n10.3233\/JAD-143099","journal-title":"J Alzheimers Dis"},{"key":"479_CR19","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s00415-015-7837-x","volume":"262","author":"F Llorens","year":"2015","unstructured":"Llorens F, Kruse N, Schmitz M et al (2015a) Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD. J Neurol 262:2305\u20132311. doi:\n10.1007\/s00415-015-7837-x","journal-title":"J Neurol"},{"key":"479_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00415-014-7334-7","volume":"261","author":"T Kasai","year":"2014","unstructured":"Kasai T, Tokuda T, Ishii R et al (2014) Increased $\u03b1$-synuclein levels in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 261:1203\u20131209. doi:\n10.1007\/s00415-014-7334-7","journal-title":"J Neurol"},{"key":"479_CR21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/nan.12175","volume":"41","author":"F Llorens","year":"2015","unstructured":"Llorens F, Zafar S, Ansoleaga B et al (2015b) Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 41:631\u2013645. doi:\n10.1111\/nan.12175","journal-title":"Neuropathol Appl Neurobiol"},{"key":"479_CR22","doi-asserted-by":"publisher","unstructured":"Llorens F, Kruse N, Schmitz M et al (2016) Evaluation of \u03b1-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases. Alzheimers Dement:1\u201310. doi:\n10.1016\/j.jalz.2016.09.013","DOI":"10.1016\/j.jalz.2016.09.013"},{"key":"479_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","volume":"124","author":"P Parchi","year":"2012","unstructured":"Parchi P, De Boni L, Saverioni D et al (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124:517\u2013529. doi:\n10.1007\/s00401-012-1002-8","journal-title":"Acta Neuropathol"},{"key":"479_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32\u201335. doi:\n10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","journal-title":"Cancer"},{"key":"479_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00179","author":"U Andreasson","year":"2015","unstructured":"Andreasson U, Perret-Liaudet A, van Waalwijk van Doorn LJC et al (2015) A practical guide to immunoassay method validation. Front Neurol. doi:\n10.3389\/fneur.2015.00179","journal-title":"Front Neurol"},{"key":"479_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2377-11-120","volume":"11","author":"Y Matsui","year":"2011","unstructured":"Matsui Y, Satoh K, Miyazaki T et al (2011) High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease. BMC Neurol 11:120. doi:\n10.1186\/1471-2377-11-120","journal-title":"BMC Neurol"},{"key":"479_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9167-5","author":"M Schmitz","year":"2015","unstructured":"Schmitz M, Ebert E, Stoeck K et al (2015) Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic. Mol Neurobiol. doi:\n10.1007\/s12035-015-9167-5","journal-title":"Mol Neurobiol"},{"key":"479_CR28","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00415-006-0472-9","volume":"254","author":"P Sanchez-Juan","year":"2007","unstructured":"Sanchez-Juan P, S\u00e1nchez-Valle R, Green A et al (2007) Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis. J Neurol 254:901\u2013906. doi:\n10.1007\/s00415-006-0472-9","journal-title":"J Neurol"},{"key":"479_CR29","doi-asserted-by":"publisher","unstructured":"Llorens F, Schmitz M, Karch A et al (2015c) Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia. Alzheimers Dement:1\u201313. doi:\n10.1016\/j.jalz.2015.10.009","DOI":"10.1016\/j.jalz.2015.10.009"},{"key":"479_CR30","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1136\/jnnp.74.9.1210","volume":"74","author":"B Van Everbroeck","year":"2003","unstructured":"Van Everbroeck B, Quoilin S, Boons J et al (2003) A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 74:1210\u20131214. doi:\n10.1136\/jnnp.74.9.1210","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"479_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028938","author":"R Siman","year":"2011","unstructured":"Siman R, Giovannone N, Toraskar N et al (2011) Evidence that a panel of neurodegeneration biomarkers predicts vasospasm, infarction, and outcome in aneurysmal subarachnoid hemorrhage. PLoS One. doi:\n10.1371\/journal.pone.0028938","journal-title":"PLoS One"},{"key":"479_CR32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1212\/WNL.55.4.514","volume":"55","author":"AW Lemstra","year":"2000","unstructured":"Lemstra AW, van Meegen MT, Vreyling J et al (2000) 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients. Neurology 55:514\u2013516. doi:\n10.1212\/WNL.55.4.514","journal-title":"Neurology"},{"key":"479_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1212\/WNL.0b013e31823ed0f0","volume":"78","author":"NSM Schoonenboom","year":"2012","unstructured":"Schoonenboom NSM, Reesink FE, Verwey NA et al (2012) Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78:47\u201354. doi:\n10.1212\/WNL.0b013e31823ed0f0","journal-title":"Neurology"},{"key":"479_CR34","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1007\/s00415-013-7047-3","volume":"260","author":"L Kaerst","year":"2013","unstructured":"Kaerst L, Kuhlmann A, Wedekind D et al (2013) Cerebrospinal fluid biomarkers in Alzheimer\u2019s disease, vascular dementia and ischemic stroke patients: a critical analysis. J Neurol 260:2722\u20132727. doi:\n10.1007\/s00415-013-7047-3","journal-title":"J Neurol"},{"key":"479_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/bmm.12.46","volume":"6","author":"M Campo del","year":"2012","unstructured":"del Campo M, Mollenhauer B, Bertolotto A et al (2012) Recommendations to standardize preanalytical confounding factors in Alzheimer\u2019s and Parkinson\u2019s disease cerebrospinal fluid biomarkers: an update. Biomark Med 6:419\u2013430. doi:\n10.2217\/bmm.12.46","journal-title":"Biomark Med"},{"key":"479_CR36","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jim.2015.08.003","volume":"426","author":"N Kruse","year":"2015","unstructured":"Kruse N, Mollenhauer B (2015) Validation of a commercially available enzyme-linked immunoabsorbent assay for the quantification of human\u00a0??-synuclein in cerebrospinal fluid. J Immunol Methods 426:70\u201375. doi:\n10.1016\/j.jim.2015.08.003","journal-title":"J Immunol Methods"},{"key":"479_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000112832","volume":"5","author":"R Barbour","year":"2008","unstructured":"Barbour R, Kling K, Anderson JP et al (2008) Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis 5:55\u201359. doi:\n10.1159\/000112832","journal-title":"Neurodegener Dis"},{"key":"479_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000454802","volume":"43","author":"F Llorens","year":"2017","unstructured":"Llorens F, Karch A, Golanska E et al (2017) Cerebrospinal fluid biomarker-based diagnosis of sporadic Creutzfeldt-Jakob disease: a validation study for previously established cutoffs. Dement Geriatr Cogn Disord 43:71\u201380. doi:\n10.1159\/000454802","journal-title":"Dement Geriatr Cogn Disord"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-017-0479-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0479-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T23:09:39Z","timestamp":1520291379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-017-0479-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,21]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s12035-017-0479-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,21]]}}}